Previous studies have demonstrated that TGR5 and FXR are the major receptors for bile acids, so we treated the cells with the TGR5 and FXR receptor inhibitors SBI-115 and Gly-β-MCA and treated them with LCA. This evidence concerns the gene GPBAR1 and Leber congenital amaurosis.